Manulife (Manufacturers Life Insurance)
TBPH icon

Manulife (Manufacturers Life Insurance)’s Theravance Biopharma TBPH Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$186K Buy
10,968
+244
+2% +$4.04K ﹤0.01% 2592
2026
Q1 		$174K Sell
10,724
-1,152
-10% -$20.4K ﹤0.01% 2501
2025
Q4 		$222K Sell
11,876
-414
-3% -$6.87K ﹤0.01% 2476
2025
Q3 		$179K Sell
12,290
-3,457
-22% -$43.7K ﹤0.01% 2619
2025
Q2 		$174K Buy
15,747
+1,020
+7% +$9.92K ﹤0.01% 2612
2025
Q1 		$132K Sell
14,727
-705
-5% -$6.56K ﹤0.01% 2626
2024
Q4 		$145K Sell
15,432
-179
-1% -$1.63K ﹤0.01% 2728
2024
Q3 		$126K Sell
15,611
-1,012
-6% -$8.77K ﹤0.01% 2799
2024
Q2 		$141K Sell
16,623
-2,431
-13% -$21.9K ﹤0.01% 2728
2024
Q1 		$171K Sell
19,054
-450
-2% -$4.17K ﹤0.01% 2651
2023
Q4 		$219K Sell
19,504
-4,294
-18% -$43.2K ﹤0.01% 2575
2023
Q3 		$205K Hold
23,798
– – ﹤0.01% 2589
2023
Q2 		$246K Sell
23,798
-356
-1% -$3.93K ﹤0.01% 2483
2023
Q1 		$262K Hold
24,154
– – ﹤0.01% 2388
2022
Q4 		$271K Sell
24,154
-386
-2% -$4.06K ﹤0.01% 2374
2022
Q3 		$249K Sell
24,540
-447
-2% -$4.19K ﹤0.01% 2423
2022
Q2 		$226K Buy
24,987
+724
+3% +$6.67K ﹤0.01% 2577
2022
Q1 		$232K Sell
24,263
-6,970
-22% -$68.3K ﹤0.01% 2673
2021
Q4 		$345K Sell
31,233
-2,640
-8% -$23K ﹤0.01% 2515
2021
Q3 		$251K Buy
33,873
+4,082
+14% +$45.7K ﹤0.01% 2807
2021
Q2 		$433K Buy
29,791
+3,755
+14% +$70.5K ﹤0.01% 2542
2021
Q1 		$531K Sell
26,036
-1,533
-6% -$29.1K ﹤0.01% 2231
2020
Q4 		$490K Buy
27,569
+1,436
+5% +$25.8K ﹤0.01% 2205
2020
Q3 		$386K Sell
26,133
-568
-2% -$10.6K ﹤0.01% 2129
2020
Q2 		$551K Sell
26,701
-2,327
-8% -$59.8K ﹤0.01% 1915
2020
Q1 		$671K Buy
29,028
+3,394
+13% +$84.9K ﹤0.01% 1688
2019
Q4 		$709K Sell
25,634
-1,108
-4% -$21.5K ﹤0.01% 1853
2019
Q3 		$520K Sell
26,742
-284
-1% -$5.74K ﹤0.01% 1992
2019
Q2 		$441K Sell
27,026
-452
-2% -$9.16K ﹤0.01% 2125
2019
Q1 		$623K Buy
27,478
+129
+0.5% +$3.27K ﹤0.01% 1962
2018
Q4 		$700K Sell
27,349
-264
-1% -$7.13K ﹤0.01% 1780
2018
Q3 		$902K Sell
27,613
-3,880
-12% -$106K ﹤0.01% 1874
2018
Q2 		$714K Buy
31,493
+655
+2% +$15.6K ﹤0.01% 2111
2018
Q1 		$748K Sell
30,838
-126
-0.4% -$3.46K ﹤0.01% 2033
2017
Q4 		$864K Buy
30,964
+222
+0.7% +$6.57K ﹤0.01% 1945
2017
Q3 		$1.05M Sell
30,742
-479
-2% -$15.7K ﹤0.01% 1755
2017
Q2 		$1.24M Buy
31,221
+1,175
+4% +$45.2K ﹤0.01% 1675
2017
Q1 		$1.11M Buy
30,046
+4,355
+17% +$139K ﹤0.01% 1689
2016
Q4 		$819K Buy
25,691
+1,734
+7% +$53.8K ﹤0.01% 1774
2016
Q3 		$868K Buy
23,957
+44
+0.2% +$1.23K ﹤0.01% 1724
2016
Q2 		$543K Buy
23,913
+5,888
+33% +$127K ﹤0.01% 1978
2016
Q1 		$332K Buy
18,025
+1,407
+8% +$23K ﹤0.01% 2245
2015
Q4 		$273K Buy
16,618
+352
+2% +$5.59K ﹤0.01% 2427
2015
Q3 		$179K Buy
16,266
+315
+2% +$4.01K ﹤0.01% 2735
2015
Q2 		$208K Buy
15,951
+750
+5% +$11.6K ﹤0.01% 2817
2015
Q1 		$263K Buy
15,201
+483
+3% +$8.85K ﹤0.01% 2528
2014
Q4 		$219K Buy
14,718
+99
+0.7% +$1.73K ﹤0.01% 2574
2014
Q3 		$337K Buy
14,619
+43
+0.3% +$1.25K ﹤0.01% 2260
2014
Q2 		$465K Buy
+14,576
New +$439K ﹤0.01% 2086

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
ICM
Irenic Capital Management New York $2.08B AUM 19.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s TBPH Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Theravance Biopharma (TBPH) stake by 2.3% in Q2 2026, buying an estimated $4.04K and bringing the position to 10,968 shares worth $186K. The position accounts for ﹤0.01% of the portfolio, ranked #2592.

Manulife (Manufacturers Life Insurance) first reported a position in TBPH in Q2 2014 and has held it in 49 quarters since. The position peaked at $1.24M in Q2 2017. 179 funds tracked by Wall St. Rank hold TBPH as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 10,968 shares of Theravance Biopharma worth $186K as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) bought 244 Theravance Biopharma shares in Q2 2026, an estimated $4.04K.
  • Theravance Biopharma made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #2592 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Theravance Biopharma in Q2 2014 and has held it in 49 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Theravance Biopharma position peaked at $1.24M in Q2 2017.
  • 179 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.